Assignee
MICROVAX LLC
US18 patents
Top patents by PatentIndex Score
US8742087B2Jun 3, 2014
Mucin antigen vaccine
MICROVAX LLC4 citations82
US8501707B2Aug 6, 2013
Mucin antigen vaccine
MICROVAX LLC8 citations82
US10046041B2Aug 14, 2018
Methods and compositions for suppressing virulence of methicillin resistant Staphylococcus aureus
MICROVAX LLC3 citations72
US9757438B2Sep 12, 2017
Mucin antigen vaccine
MICROVAX LLC2 citations71
US9353167B2May 31, 2016
Methods for generating immunity to antigen
MICROVAX LLC3 citations70
US12427191B1Sep 30, 2025
SARS-CoV-2 fusion protein vaccine/regimen
MICROVAX LLC0 citations62
US11097001B1Aug 24, 2021
Composition and method against tuberculosis
MICROVAX LLC1 citations62
US10183067B1Jan 22, 2019
TAA/CD4OL composition/vaccine for malaria
MICROVAX LLC1 citations62
US10166284B1Jan 1, 2019
Vaccines for herpes simplex virus 1 and 2
MICROVAX LLC1 citations62
US11839655B2Dec 12, 2023
Combination cancer therapy
MICROVAX LLC1 citations61
US11077183B2Aug 3, 2021
CD40 ligand fusion protein vaccine
MICROVAX LLC0 citations61
US9402920B2Aug 2, 2016
Mucin antigen vaccine
MICROVAX LLC2 citations61
US11154603B1Oct 26, 2021
Burkholderia pseudomallei composition
MICROVAX LLC0 citations51
US9642901B1May 9, 2017
TAA/CD40L vaccine for malaria
MICROVAX LLC1 citations51
US9526774B1Dec 27, 2016
Methods and compositions for suppressing virulence of methicillin resistant Staphylococcus aureus
MICROVAX LLC1 citations51
US10426827B1Oct 1, 2019
Dengue hemorrhagic fever virus vaccine
MICROVAX LLC0 citations41
US10293040B1May 21, 2019
Pharmaceutical compositions and methods of blocking Bacillus anthracis
MICROVAX LLC0 citations41
US10174100B1Jan 8, 2019
Multivalent DNA composition for Yersinia pestis
MICROVAX LLC0 citations41